CHARACTERIZATION OF METABOLIC AND PATHOLOGICAL INTERACTIONS IN ALZHEIMER'S DISEASE DEVELOPMENT AND THEIR REGULATION BY CENTRAL PRAMLINTIDE TREATMENT

CHARACTERIZATION OF METABOLIC AND PATHOLOGICAL INTERACTIONS IN ALZHEIMER'S DISEASE DEVELOPMENT AND THEIR REGULATION BY CENTRAL PRAMLINTIDE TREATMENT

Bibliographic Details
Main Author:	Grizzanti, John
Language:	English
Published:	Kent State University / OhioLINK 2020
Subjects:	Neurosciences
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=kent158764884073487

Similar Items

Elucidating the role of Cystatin C in Alzheimer's disease pathology
by: Marcellus, Kristen
Published: (2014)

BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology
by: Liansheng Zhang, et al.
Published: (2021-09-01)

Neurotransmitter-specific synaptic alteration in the Alzheimer's disease and amyloid pathologies
by: Bell, Karen F
Published: (2007)

Probing the In Vivo Economy of Amyloid Beta-Protein during the Development of Alzheimer's Disease-Type Pathology
by: Hong, Soyon Youngae
Published: (2012)

Effects of Pramlintide on Mitochondrial Dynamics and Health in the Alzheimer's Disease APP/PS1 Mouse Model
by: Paliobeis, Andrew S.
Published: (2017)

Characterization of the sleep-wake cycle in the TgCRND8 mouse model of Alzheimer's disease: from early to advanced pathological stages
by: Colby-Milley, Jessica
Published: (2014)

Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease
by: Margaret O'Connor, et al.
Published: (2020-09-01)

SURVEY OF CNS EXPRESSION OF THE AMYLIN RECEPTOR IN HEALTH AND METABOLIC DISEASE: POTENTIAL RELEVANCE TO ALZHEIMER'S DISEASE
by: Servizi, Spencer
Published: (2019)

Heme Oxygenase-1/sterol interactions in Alzheimer's disease
by: Hascalovici, Jacob
Published: (2013)

The Characterization of Alzheimer’s Disease and the Development of Early Detection Paradigms: Insights from Nosology, Biomarkers and Machine Learning
by: Milano, Isabel
Published: (2019)

Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
by: Tim A Briscoe,&nbsp;Lynette Jobe, et al.
Published: (2008-10-01)

Characterizing and exploiting the amyloid precursor protein-mint1 interaction as an Alzheimer’s disease therapeutic target
by: Henry, Shawna M.
Published: (2021)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
by: Al-Keilani MS, et al.
Published: (2018-03-01)

Discovery and characterization of novel drugs for Treatment of Alzheimer disease from a high-throughput compound screen
by: Honarnejad, Kamran
Published: (2014)

PPARɣ Activation Rapidly Ameliorates Amyloid Pathology and Restores Cognition in a Mouse Model of Alzheimer’s Disease
by: Mandrekar-Colucci, Shweta Dilip
Published: (2011)

PRECLINICAL TARGETING OF TREM2 FOR THE TREATMENT OF ALZHEIMER'S DISEASE-TYPE PATHOLOGY IN A TRANSGENIC MOUSE MODEL
by: Price, Brittani Rae
Published: (2019)

Meta-Analysis of Exenatide, the Sitagliptin, and Pramlintide Compared to Placebo for Treatment of Type II Diabetes.
by: Rowell, Jonathan, et al.
Published: (2010)

FDG PET and MRI as biomarkers of Tau pathology in Alzheimer’s disease
by: Ekaputri, Putu Ayuwidia
Published: (2021)

Alzheimer's disease pathology in aged chimpanzees
by: Edler, Melissa K.
Published: (2016)

CYTOSKELETAL PROTEIN DYSFUNCTION AND OXIDATIVE MODIFICATION IN ALZHEIMERS DISEASE
by: Boutte, Angela Monique
Published: (2005)

Modeling Alzheimer's Disease Using Cellular Reprogramming Technologies
by: Chau, Lily
Published: (2012)

Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
by: John Pullman, et al.
Published: (2006-09-01)

Examining the relationship between mitochondrial dysfunction and Parkinson's disease pathology: a review on potential risk factors and treatments for parkinsonism
by: Bonilla, Harrison
Published: (2019)

Caspase-6a activation is regulated by Caspase-6b, implications for a potential inhibitor of Alzheimer Disease
by: Lee, Andrea
Published: (2011)

Cerebrovasculature and Cognition in Middle Aged Adults At Risk for Alzheimer's Disease
by: Mason, Emily Jo
Published: (2016)

Nerve Growth Factor, Aging and Alzheimer's disease
by: Bruno, Martin
Published: (2008)

Study of forced degradation behavior of pramlintide acetate by HPLC and LC–MS
by: Yu Yuan, et al.
Published: (2018-01-01)

The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro
by: Leila Safaeian, et al.
Published: (2020-01-01)

Modifiers of Beta-Amyloid Metabolism and Deposition in Mouse Models of Alzheimer's Disease
by: Schrump, Stefanie
Published: (2011)

Insights on Alzheimer's Disease Etiology from Network Approaches in Healthy Aging
by: Arnemann, Katelyn Laurel
Published: (2018)

Tau-Directed Immunotherapy for Alzheimer's Disease
by: Schroeder, Sulana K.
Published: (2017)

Alteration in synaptic nanoscale organization dictates amyloidogenic processing in Alzheimer's disease
by: Shekhar Kedia, et al.
Published: (2021-01-01)

The Role of HIV-1 Proteins in Alzheimer's Disease Pathology
by: Giunta, Brian Nelson
Published: (2011)

Stressed Astrocytes: Insights on the Pathology of Alexander Disease
by: Guilfoyle, Eileen M.
Published: (2013)

Impact of therapeutics on neuroanatomical plasticity and cerebrovascular proteome in Alzheimer's disease mouse
by: Badhwar, Amanpreet
Published: (2013)

Genetic markers of neurodegeneration: a role for paraoconase 1 in sporadic Alzheimer's disease?
by: Leduc, Valérie
Published: (2009)

Investigating the Role of the Amyloid Precursor Protein in the Pathogenesis of Alzheimer's Disease
by: Lefort, Roger
Published: (2011)

Antibody Based Therapeutics for Alzheimer's DIsease
Published: (2011)

Alzheimer’s Disease Pathology as a Clue to Pathogenesis
by: Funk, Kristen E.
Published: (2012)

á1-ADRENERGIC RECEPTOR REGULATION OF EXCITATORY TRANSMISSION IN THE BED UCLEUS OF THE STRIA TERMINALIS: CHARACTERIZATION, MECHANISM, AND POTENTIAL ROLE IN DISEASE
by: McElligott, Zoe Anastasia
Published: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jl7nku93sjmuqlk9uapmceff6i